Comparison of FDG‐PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis
Authors:
Open Access
- 12 November 2008
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 52 (1) , 97-101
Abstract
Background: We evaluated the effectiveness of FDG‐PET scans in identifying sites of active disease and assessing response to therapy in patients with Langerhans cell histiocytosis (LCH). Changes in standardized uptake value (SUV) indicated increased or decreased disease activity before changes are evident by plain films or bone scans.Methods: One hundred and two PET scans for 44 patients (41 children, 3 adults) with biopsy‐proven LCH were compared with 83 corollary imaging modalities and were rated for overall clinical utility: false positive or negative (“inferior”), confirming lesions identified by another imaging modality (“confirmatory”), or showing additional lesions, response to therapy or recurrence of disease activity (“superior”), in comparison to bone scans, MRI, CT or plain films.Results: FDG‐PET was rated superior in that 90/256 (35%) new, recurrent, or lesions responding to therapy were identified via change in standard uptake value (SUV) before other radiographic changes. PET scans confirmed active LCH in 146/256 (57%). FDG‐PET was superior to bone scans in that 8/23 (34%) lesions, 11/53 (21%) comparisons to lesions found by MRI, 13/64 (20%) CT, and 58/116 (50%) plain films. PET scans confirmed lesions found by: 14/23 (61%) bone scans, 33/53 (62%) MRI, 45/64 (65%) CT, and 54/116 (46%) of plain films.Conclusions: Whole body FDG‐PET scans can detect LCH activity and early response to therapy with greater accuracy than other imaging modalities in patients with LCH lesions in the bones and soft tissues. Whole‐body FDG‐PET scanning is an important and informative study at diagnosis and for following disease course in patients with LCH. Pediatr Blood Cancer 2009;52:97–101.Keywords
This publication has 14 references indexed in Scilit:
- Langherans Cell Histiocytosis of the Thyroid Gland Detected by 18FDG-PET/CTThe Journal of Clinical Endocrinology & Metabolism, 2007
- PET-CT in pediatric Langerhans cell histiocytosisPediatric Radiology, 2007
- Defining the Role of Magnetic Resonance Imaging in Unifocal Bone Lesions of Langerhans Cell HistiocytosisJournal of Pediatric Hematology/Oncology, 2005
- Langerhans cell histiocytosis with central nervous system involvement: Follow‐up by FDG‐PET during treatment with cladribinePediatric Blood & Cancer, 2004
- Langerhans? cell histiocytosis: pathology, imaging and treatment of skeletal involvementPediatric Radiology, 2004
- Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findingsPediatric Radiology, 2003
- Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosisThe Journal of Pediatrics, 2002
- Role of 18 FDG-positron Emission Tomography Scanning in the Management of HistiocytosisLeukemia & Lymphoma, 2002
- Detection of Bone Lesions in Langerhans Cell HistiocytosisJournal of Pediatric Hematology/Oncology, 1996
- Eosinophilic Granuloma of BoneMedical and Pediatric Oncology, 1980